News White paper reveals pathway for digital therapeutics use in ... A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx).
Views & Analysis 2021 market access prospects for Italy Italy was working up big changes in market access throughout 2020 which will be implemented in 2021.
Press releases Partner Content Partnership to launch Italy's first hypertension digital the... Milan, Italy - July 23rd 2018 -
News Pulmonary fibrosis drug developer Avalyn files IPO Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
